ARACELI GONZALEZ: Open Payments
NPI 1861086480 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,079 in 51 payments from 16 companies in 2025. Trend: 2023 $955 · 2024 $918 · 2025 $1,079
Food & beverage: $1,079
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $173 |
| AstraZeneca Pharmaceuticals LP | 6 | $170 |
| Novo Nordisk Inc | 8 | $152 |
| PFIZER INC. | 6 | $144 |
| Lilly USA, LLC | 4 | $74 |
| Dexcom, Inc. | 3 | $68 |
| Merck Sharp & Dohme LLC | 3 | $51 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
Products named: UBRELVY, AIRSUPRA, Dexcom G6 Transmitter, NURTEC ODT, JARDIANCE, TRUMENBA, MOUNJARO, SHINGRIX.
Industry payments across WI — which companies pay providers there.
